Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Opus Genetics Inc (NASDAQ: IRD) closed the day trading at $1.93 down -3.50% from the previous closing price of $2.0. In other words, the price has decreased by -$3.50 from its previous closing price. On the day, 0.6 million shares were traded. IRD stock price reached its highest trading level at $2.02 during the session, while it also had its lowest trading level at $1.885.
Ratios:
For a better understanding of IRD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.23 and its Current Ratio is at 1.23. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In the most recent recommendation for this company, B. Riley Securities on December 10, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On November 25, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $7.
On October 29, 2025, Wedbush started tracking the stock assigning a Outperform rating and target price of $8.Wedbush initiated its Outperform rating on October 29, 2025, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 29 ’25 when Gallagher Cam bought 83,000 shares for $1.97 per share. The transaction valued at 163,419 led to the insider holds 83,000 shares of the business.
Gallagher Cam bought 81,000 shares of IRD for $160,275 on Dec 29 ’25. The Director now owns 1,891,430 shares after completing the transaction at $1.98 per share. On Dec 09 ’25, another insider, Foundation Fighting Blindness, who serves as the Director of the company, sold 4,000,000 shares for $2.15 each. As a result, the insider received 8,600,000 and left with 5,492,171 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IRD now has a Market Capitalization of 133100920 and an Enterprise Value of 103353920. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.43 while its Price-to-Book (P/B) ratio in mrq is 20.88. Its current Enterprise Value per Revenue stands at 7.063 whereas that against EBITDA is -2.784.
Stock Price History:
The Beta on a monthly basis for IRD is 0.58, which has changed by 0.5950413 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, IRD has reached a high of $2.59, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -6.34%, while the 200-Day Moving Average is calculated to be 36.28%.
Shares Statistics:
Over the past 3-months, IRD traded about 511.03K shares per day on average, while over the past 10 days, IRD traded about 427420 shares per day. A total of 64.54M shares are outstanding, with a floating share count of 54.33M. Insiders hold about 21.38% of the company’s shares, while institutions hold 22.29% stake in the company. Shares short for IRD as of 1765756800 were 635920 with a Short Ratio of 1.24, compared to 1763078400 on 386397. Therefore, it implies a Short% of Shares Outstanding of 635920 and a Short% of Float of 0.9599999499999999.
